TMCnet News
Global Tumor Markers Immunoassay Market Analysis, 2025 - PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others - ResearchAndMarkets.comThe "Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)" report has been added to ResearchAndMarkets.com's offering. Immunoassays have played a role in cancer management since the 1960s with the discovery of tumor markers alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). These two tests are still an essential part of the cancer diagnostics toolbox. Tumor Markers Immunoassay Market provides analysis of the current global market, including the following data points:
Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Much of the activity in the development and use of new biomarkers is in the field of oncology, where both single biomakers and also biomarker panels are being developed and used for a wide range of applications - assessing risk of developing cancer, screening apparently healthy individuals for cancer, diagnosis of cancer, predicting prognosis, monitoring patients including monitoring for recurrence of disease, and determining the best therapy for treatment of a patient. Researchers are continuing to try to identify and validate new tumor biomarkers, but this has proven to be a slow process. Still, biomarker assays are being developed and added to the menus of large analyzers. Key Topics Covered: 1: Executive Summary OVERVIEW Table 1-1: Selected Widely Used Tumor Markers CONCLUSIONS The Current Global Market The Tumor Markers Market Is at the Same Time Impressive and Distressing Researchers Are Continuing to Try to Identify and Validate New Tumor Biomarkers 2: Tumor Markers Immunoassay Market: Analysis TUMOR MARKERS AFP (alfa-fetoprotein) Beta HCG CA 125 CA 15-3 CA 19-9 CEA (carcinoembryonic antigen) CYFRA 21-1 HE4 (human epididymis protein 4) ProGRP PSA (complexed, free, total) SCC (squamous cell carcinoma antigen) Serum HER-2/neu Thyroglobulin CA 72-4 COMPANIES IN THE MARKET MARKET ANALYSIS 3: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/33qx55/global_tumor?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20180122005831/en/ |